Inventor · disambiguated record

Zhoufan Xie

Also filed as: Xie Zhoufan

2 granted patents·1 pending application·1 citations·filing 2020–2021

29Inventor score

Technology areasC07D

Files withGUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO LTD BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY3

Top patents by PatentIndex Score

3 records

0173US12297197B2Pyrazolopyridine compound as RET inhibitor and application thereofGUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO LTD BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY·Filed 2020·Granted May 13, 2025·1 cites·19 claims
0249US2023365596A1Crystal forms of pyridopyrazole compounds and preparation method thereforGUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO LTD BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY·Filed 2021·Application pending·0 cites
0344US12240849B2Nitrogen-containing spiro derivative as RET inhibitorGUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO LTD BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY·Filed 2020·Granted Mar 4, 2025·0 cites·19 claims

Join the waitlist — get patent alerts

Get an alert when Zhoufan Xie files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →